Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ef10ff6d1c611582b8ad62e8a4d6617 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242714f8094d5ad279c30275b8a60e0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3876dc544d767dff04606c53e4bc6f4e |
publicationDate |
2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1915175-A2 |
titleOfInvention |
Direct and indirect effector cell protease receptor-1 (epr-1) inhibitors as antiplatelet agents |
abstract |
Direct and indirect effector cell protease receptor-1 (EPR-1) inhibitors may be used for the treatment of conditions associated with platelet aggregation as antiplatelet agents. |
priorityDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |